Assessment of pulmonary surfactant in COVID-19 patients

Crit Care. 2020 Sep 7;24(1):552. doi: 10.1186/s13054-020-03268-9.
No abstract available

Keywords: ARDS; COVID-19; Pulmonary surfactant.

MeSH terms

  • COVID-19
  • Coronavirus Infections / complications
  • Coronavirus Infections / therapy*
  • Humans
  • Pandemics
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / therapy*
  • Pulmonary Surfactants / analysis*
  • Respiratory Distress Syndrome / virology

Substances

  • Pulmonary Surfactants